Research Article

Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study

Table 5

Comparison of changes in HbA1c and BMI for 6 months between the dula continuation group and the switching group. Study 2.

ParameterDula continuationSwitching value

ΔHbA1c (%)0.048
Δ BMI (kg/m2)0.042

Abbreviations: BMI: body mass index. Data are shown as .